Skip to main content

Table 2 Associations of maternal urinary DON levels (ng/mL) during pregnancy with birth outcomes

From: Adverse associations between maternal deoxynivalenol exposure and birth outcomes: a prospective cohort study in China

 

Birth weight (g)

Birth length (cm)

Small for gestational age

β (95%CI)

β (95%CI)

Case (%)

OR (95%CI)

Total DON

 Ln-tDON

-22.00 (-37.11, -6.89)

-0.03 (-0.08, 0.03)

130 (8.45)

1.09 (0.94, 1.27)

 T1

ref

ref

37 (7.23)

ref

 T2

-21.42 (-67.01, 24.13)

0.08 (-0.08, 0.24)

44 (8.53)

1.28 (0.84, 2.04)

 T3

-81.11 (-127.00, -35.23)

-0.15 (-0.31, 0.01)

49 (9.61)

1.44 (0.91, 2.28)

 P for trend

 < 0.001

0.021

 

0.149

Free DON

 Ln-fDON

-17.70 (-29.72, -5.69)

-0.04 (-0.08, 0.01)

130 (8.45)

1.10 (0.97, 1.24)

 T1

ref

ref

41 (7.98)

ref

 T2

-10.84 (-56.39, 34.70)

-0.02 (-0.18, 0.14)

39 (7.63)

1.01 (0.63, 1.61)

 T3

-63.02 (-108.72, -17.32)

-0.13 (-0.28, 0.03)

50 (9.75)

1.33 (0.85, 2.07)

P for trend

0.004

0.101

 

0.160

  1. Abbreviations: DON deoxynivalenol, fDON total DON, tDON free DON, OR odds ratio, CI confidence interval
  2. Adjusted Model: adjusted for age, pre-pregnancy BMI, weight, average personal income, education attainment, parity, abnormal pregnancy-labor history, morning sickness, alcohol intake, smoking, season of sample collection, infant sex, and gestational age at delivery